New Male Birth Control Pill Could Stop Sperm Movement Within 30 Minutes: How Does It Work?

Experimental Male Birth Control Pill Could Temporarily Stop Sperm From Swimming

Women have access to a wide range of contraceptive methods, while male birth control options are still largely limited to condoms and vasectomy. Scientists are working to change this by developing an experimental contraceptive pill that could temporarily prevent pregnancy by making sperm unable to move.

The research, being conducted by scientists at Weill Cornell Medicine in the United States, focuses on a non-hormonal approach to male contraception. Early findings suggest that the drug could affect sperm movement within approximately 30 minutes of consumption, with its contraceptive effect potentially lasting six to eight hours.

Unlike vasectomy, the proposed method is designed to be reversible. Researchers believe that normal sperm movement and fertility could return after the drug’s effects wear off. However, these results are based on preliminary research, and the proposed timings have not yet been confirmed in human trials.

How Does The Experimental Pill Work?

Scientists Dr Jochen Buck and Dr Lonny Levin are leading research into a new approach that targets an enzyme called soluble adenylyl cyclase (sAC).

This enzyme plays an important role in sperm movement by helping activate the mechanisms that allow sperm to swim. Without sufficient activity of sAC, sperm struggle to move effectively and reach an egg for fertilisation.

The experimental drug works by temporarily inhibiting this enzyme. Researchers hope that blocking sAC will make sperm temporarily immobile, preventing them from reaching and fertilising an egg.

Once the drug leaves the body and its effects disappear, sAC activity is expected to resume, potentially restoring normal sperm movement without permanently affecting fertility.

What Do Early Studies Reveal About Safety?

Preliminary experiments in animals have provided encouraging results, with researchers reporting no obvious short-term side effects. However, this does not establish that the drug is safe for humans.

One of the major challenges is determining whether inhibiting sAC could affect other bodily functions, since the enzyme is not exclusively involved in sperm activity.

Researchers will need to conduct extensive safety assessments to understand possible side effects, determine appropriate dosages and establish whether repeated use could create any long-term health risks.

When Could The Male Birth Control Pill Reach The Market?

The experimental contraceptive is still in the development phase. Researchers are working towards human clinical trials, but the drug must undergo further testing before its safety and effectiveness can be established.

Human studies will need to examine how quickly the pill works, how long its effects last, whether it consistently prevents pregnancy and how quickly fertility returns after discontinuing its use.

If clinical trials produce successful results, the development could represent a significant step towards expanding contraceptive choices for men. However, the pill is not currently available as an approved birth control method, and its eventual launch will depend on the outcome of further research and regulatory approval.